Cargando…

Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis

Background: Fibrotic hypersensitivity pneumonitis (fHP) shares many features with other fibrotic interstitial lung diseases (ILD), and as a result it can be misdiagnosed as idiopathic pulmonary fibrosis (IPF). We aimed to determine the value of bronchoalveolar lavage (BAL) total cell count (TCC) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobiecka, Małgorzata, Szturmowicz, Monika, Lewandowska, Katarzyna B., Barańska, Inga, Zimna, Katarzyna, Łyżwa, Ewa, Dybowska, Małgorzata, Langfort, Renata, Radwan-Röhrenschef, Piotr, Roży, Adriana, Tomkowski, Witold Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000588/
https://www.ncbi.nlm.nih.gov/pubmed/36900078
http://dx.doi.org/10.3390/diagnostics13050935
_version_ 1784903914920869888
author Sobiecka, Małgorzata
Szturmowicz, Monika
Lewandowska, Katarzyna B.
Barańska, Inga
Zimna, Katarzyna
Łyżwa, Ewa
Dybowska, Małgorzata
Langfort, Renata
Radwan-Röhrenschef, Piotr
Roży, Adriana
Tomkowski, Witold Z.
author_facet Sobiecka, Małgorzata
Szturmowicz, Monika
Lewandowska, Katarzyna B.
Barańska, Inga
Zimna, Katarzyna
Łyżwa, Ewa
Dybowska, Małgorzata
Langfort, Renata
Radwan-Röhrenschef, Piotr
Roży, Adriana
Tomkowski, Witold Z.
author_sort Sobiecka, Małgorzata
collection PubMed
description Background: Fibrotic hypersensitivity pneumonitis (fHP) shares many features with other fibrotic interstitial lung diseases (ILD), and as a result it can be misdiagnosed as idiopathic pulmonary fibrosis (IPF). We aimed to determine the value of bronchoalveolar lavage (BAL) total cell count (TCC) and lymphocytosis in distinguishing fHP and IPF and to evaluate the best cut-off points discriminating these two fibrotic ILD. Methods: A retrospective cohort study of fHP and IPF patients diagnosed between 2005 and 2018 was conducted. Logistic regression was used to evaluate the diagnostic utility of clinical parameters in differentiating between fHP and IPF. Based on the ROC analysis, BAL parameters were evaluated for their diagnostic performance, and optimal diagnostic cut-offs were established. Results: A total of 136 patients (65 fHP and 71 IPF) were included (mean age 54.97 ± 10.87 vs. 64.00 ± 7.18 years, respectively). BAL TCC and the percentage of lymphocytes were significantly higher in fHP compared to IPF (p < 0.001). BAL lymphocytosis >30% was found in 60% of fHP patients and none of the patients with IPF. The logistic regression revealed that younger age, never smoker status, identified exposure, lower FEV(1), higher BAL TCC and higher BAL lymphocytosis increased the probability of fibrotic HP diagnosis. The lymphocytosis >20% increased by 25 times the odds of fibrotic HP diagnosis. The optimal cut-off values to differentiate fibrotic HP from IPF were 15 × 10(6) for TCC and 21% for BAL lymphocytosis with AUC 0.69 and 0.84, respectively. Conclusions: Increased cellularity and lymphocytosis in BAL persist despite lung fibrosis in HP patients and may be used as important discriminators between IPF and fHP.
format Online
Article
Text
id pubmed-10000588
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100005882023-03-11 Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis Sobiecka, Małgorzata Szturmowicz, Monika Lewandowska, Katarzyna B. Barańska, Inga Zimna, Katarzyna Łyżwa, Ewa Dybowska, Małgorzata Langfort, Renata Radwan-Röhrenschef, Piotr Roży, Adriana Tomkowski, Witold Z. Diagnostics (Basel) Article Background: Fibrotic hypersensitivity pneumonitis (fHP) shares many features with other fibrotic interstitial lung diseases (ILD), and as a result it can be misdiagnosed as idiopathic pulmonary fibrosis (IPF). We aimed to determine the value of bronchoalveolar lavage (BAL) total cell count (TCC) and lymphocytosis in distinguishing fHP and IPF and to evaluate the best cut-off points discriminating these two fibrotic ILD. Methods: A retrospective cohort study of fHP and IPF patients diagnosed between 2005 and 2018 was conducted. Logistic regression was used to evaluate the diagnostic utility of clinical parameters in differentiating between fHP and IPF. Based on the ROC analysis, BAL parameters were evaluated for their diagnostic performance, and optimal diagnostic cut-offs were established. Results: A total of 136 patients (65 fHP and 71 IPF) were included (mean age 54.97 ± 10.87 vs. 64.00 ± 7.18 years, respectively). BAL TCC and the percentage of lymphocytes were significantly higher in fHP compared to IPF (p < 0.001). BAL lymphocytosis >30% was found in 60% of fHP patients and none of the patients with IPF. The logistic regression revealed that younger age, never smoker status, identified exposure, lower FEV(1), higher BAL TCC and higher BAL lymphocytosis increased the probability of fibrotic HP diagnosis. The lymphocytosis >20% increased by 25 times the odds of fibrotic HP diagnosis. The optimal cut-off values to differentiate fibrotic HP from IPF were 15 × 10(6) for TCC and 21% for BAL lymphocytosis with AUC 0.69 and 0.84, respectively. Conclusions: Increased cellularity and lymphocytosis in BAL persist despite lung fibrosis in HP patients and may be used as important discriminators between IPF and fHP. MDPI 2023-03-01 /pmc/articles/PMC10000588/ /pubmed/36900078 http://dx.doi.org/10.3390/diagnostics13050935 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sobiecka, Małgorzata
Szturmowicz, Monika
Lewandowska, Katarzyna B.
Barańska, Inga
Zimna, Katarzyna
Łyżwa, Ewa
Dybowska, Małgorzata
Langfort, Renata
Radwan-Röhrenschef, Piotr
Roży, Adriana
Tomkowski, Witold Z.
Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
title Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
title_full Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
title_fullStr Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
title_full_unstemmed Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
title_short Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
title_sort bronchoalveolar lavage cell count and lymphocytosis are the important discriminators between fibrotic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000588/
https://www.ncbi.nlm.nih.gov/pubmed/36900078
http://dx.doi.org/10.3390/diagnostics13050935
work_keys_str_mv AT sobieckamałgorzata bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis
AT szturmowiczmonika bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis
AT lewandowskakatarzynab bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis
AT baranskainga bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis
AT zimnakatarzyna bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis
AT łyzwaewa bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis
AT dybowskamałgorzata bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis
AT langfortrenata bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis
AT radwanrohrenschefpiotr bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis
AT rozyadriana bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis
AT tomkowskiwitoldz bronchoalveolarlavagecellcountandlymphocytosisaretheimportantdiscriminatorsbetweenfibrotichypersensitivitypneumonitisandidiopathicpulmonaryfibrosis